Production (Stage)
Creative Medical Technology Holdings, Inc.
CELZ
$2.14
-$0.04-1.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.09M | -5.49M | -5.32M | -5.73M | -5.28M |
| Total Depreciation and Amortization | 111.80K | 110.50K | 113.40K | 107.10K | 100.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.10K | 36.80K | 2.70K | 2.70K | 2.70K |
| Change in Net Operating Assets | -48.70K | 45.00K | -44.70K | 56.40K | 89.60K |
| Cash from Operations | -6.00M | -5.30M | -5.25M | -5.57M | -5.08M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -200.00K | 6.32M | 7.25M | 9.47M | 4.93M |
| Cash from Investing | -200.00K | 6.32M | 7.25M | 9.47M | 4.93M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.99M | 1.63M | -- | -- | -- |
| Repurchase of Common Stock | -102.20K | -175.00K | -254.20K | -420.50K | -353.80K |
| Issuance of Preferred Stock | 100.00 | 100.00 | 100.00 | 100.00 | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.89M | 1.45M | -254.10K | -420.40K | -353.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.30M | 2.47M | 1.75M | 3.48M | -508.80K |